Synthorx (THOR) News Today → A.I. Pioneer Issues Urgent Warning to Americans (From TradeSmith) (Ad) Free THOR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDesign Therapeutics, Inc. (DSGN) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 21 at 4:55 PMDesign Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcriptinsidermonkey.com - March 20 at 3:52 PMEndeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. as President and Vishaal Turakhia as Chief Financial Officerfinance.yahoo.com - March 14 at 10:35 AMEndeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. to Board of Directorsfinance.yahoo.com - December 19 at 10:44 AMBiosimilar Interleukins Global Market Report 2023uk.finance.yahoo.com - February 16 at 10:03 AMImmunOs Therapeutics Announces Appointment of Joseph Leveque, MD, to its Board of Directors - Yahoo Finance UKuk.finance.yahoo.com - October 4 at 2:57 PMCapstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering - Business Wirebusinesswire.com - September 14 at 8:34 AMMedikine Initiates First Clinical Trial of its Lead Program, an Interleukin-7 Mimetic, Under Management Team with Expertise in Next-Generation Cytokine Drug Discovery and Development - Business Wirebusinesswire.com - July 19 at 5:48 PMForm SC 14D9 Turning Point Therapeuti Filed by: Turning Point Therapeutics, Inc. - StreetInsider.comstreetinsider.com - June 17 at 11:06 PMVBK: Why Growth Investors Should Avoid The Small-Caps (NYSEARCA:VBK) - Seeking Alphaseekingalpha.com - June 9 at 5:02 PMElevateBio Announces Jill M. Mooney, Ph.D., Joins as Senior Vice President of Research and Development - Yahoo Financefinance.yahoo.com - June 2 at 8:25 AMForm DEF 14A Janux Therapeutics, Inc. For: Jun 14 - StreetInsider.comstreetinsider.com - April 30 at 2:26 AMU.S. Stocks Pull Back Sharply, Contributing To Nasdaq's Worst Month Since 2008 - Nasdaqnasdaq.com - April 29 at 9:25 PMSanofi (SNY) Q1 2022 Earnings Call Transcript - The Motley Foolfool.com - April 29 at 9:25 PMGlobal Immune Checkpoint Inhibitors Market Size, Share & Industry Trends Analysis Report By Application, By Type, By Regional Outlook and Forecast, 2021 - 2027 - Yahoo Financefinance.yahoo.com - April 4 at 8:40 AMGennao Bio Strengthens Board of Directors with Appointments of Peter Thompson, MD, and Bradley Campbell - StreetInsider.comstreetinsider.com - March 17 at 6:46 PMImmuno-Oncology Drugs Global Market Report 2022nz.finance.yahoo.com - March 8 at 10:07 AMImmuno-Oncology Drugs Global Market Report 2022 - Benzinga - Benzingabenzinga.com - March 5 at 12:01 AMA $28.8 Billion Global Opportunity for Synthetic Biology by 2026 - New Research from StrategyR - Benzinga - Benzingabenzinga.com - March 3 at 5:27 PMProtein Inhibitors Global Market Report 2022 - Yahoo Financefinance.yahoo.com - March 3 at 7:47 AMA $28.8 Billion Global Opportunity for Synthetic Biology by 2026 - New Research from StrategyR - PR Newswireprnewswire.com - March 3 at 7:47 AMImmuno-Oncology Drugs Global Market Report 2022 - Yahoo Financefinance.yahoo.com - March 3 at 7:47 AMOrbiMed Names Two New General Partners - Business Wirebusinesswire.com - December 7 at 2:59 PMOrbiMed Names Two New General Partners - StreetInsider.comstreetinsider.com - December 7 at 9:56 AMMedicenna Therapeutics: Treating Cancer With Immunomodulators - Seeking Alphaseekingalpha.com - November 13 at 10:08 AMNektar: The Anatomy Of A Shakedown - Seeking Alphaseekingalpha.com - November 10 at 1:57 PMOnchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officerfinance.yahoo.com - October 28 at 9:53 AMOnchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officer - StreetInsider.comstreetinsider.com - October 26 at 12:06 PMJoint Pain Injections Market Surpass - US$ 10.3 Bn by 2028 - GlobeNewswireglobenewswire.com - September 30 at 11:41 AMImmuno-Oncology Drugs Global Market Report 2021 - ResearchAndMarkets.com - Business Wirebusinesswire.com - September 29 at 3:38 PMBiosimilar Interleukins Global Market Report 2021: COVID-19 Growth And Change To 2030 - Yahoo Financefinance.yahoo.com - September 27 at 8:24 AMImmuno-Oncology Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030uk.finance.yahoo.com - September 24 at 10:07 AMNektar And Bristol Myers Squibb Expecting Bempeg Approval - Seeking Alphaseekingalpha.com - September 18 at 10:29 AMSanofi (SNY) to Buy Kadmon for $1.9B, Add cGVHD Drug Rezurock - Nasdaqnasdaq.com - September 8 at 4:27 PMMeet the top young leaders transforming the biotech industrybusinessinsider.com - September 8 at 8:57 AMWill only a handful of companies solve the childcare crisis? - Fortunefortune.com - August 24 at 7:56 AMAristea Appoints Justin Thacker as Chief Financial Officer - Yahoo Financeyahoo.com - August 23 at 4:55 PMAristea Appoints Justin Thacker as Chief Financial Officer - Markets Insidermarkets.businessinsider.com - August 23 at 8:29 AMSanofi SA (SNY) CEO Paul Hudson on Q2 2021 Results - Earnings Call Transcript - Seeking Alphaseekingalpha.com - July 29 at 7:35 PM Get Synthorx News Delivered to You Automatically Sign up to receive the latest news and ratings for THOR and its competitors with MarketBeat's FREE daily newsletter. Email Address A.I. Pioneer Issues Urgent Warning to Americans (Ad)According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.” Click here to learn more while there’s still time. THOR Media Mentions By Week THOR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. THOR News Sentiment▼0.000.47▲Average Medical News Sentiment THOR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. THOR Articles This Week▼00▲THOR Articles Average Week Get Synthorx News Delivered to You Automatically Sign up to receive the latest news and ratings for THOR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Dyne Therapeutics News Today Maravai LifeSciences News Today PTC Therapeutics News Today Rocket Pharmaceuticals News Today Keros Therapeutics News Today Galapagos News Today Janux Therapeutics News Today TG Therapeutics News Today Vera Therapeutics News Today Schrödinger News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:THOR) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profits[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchCould Bitcoin Literally FORCE This Crypto To Rocket Up?Paradigm PressTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synthorx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.